Baseline characteristics of patients with ITP and healthy controls
| . | ITP . | Healthy control . |
|---|---|---|
| Number of individuals | 9 | 9 |
| Age, y | 62 (51-71) | ∗ |
| Males/females (n/n) | 8/1 | ∗ |
| ITP category (chronic/new diagnosis) | 4/5 | |
| Platelet count, ×103/μL blood | 8.5 (1-45) P < .00001† | 194 (173-218) |
| Mean platelet volume (fL) | 8.91 (7.60- 9.75) P = .013† | 7.07 (7.0-8.0) |
| RBC count, ×109/μL blood | 4.14 (3.94-4.45) | 4.22 (3.64-4.58) |
| Hemoglobin, g/dL | 132 (127-138) | 134 (121-146) |
| Hematocrit, % | 0.376 (0.351-0.399) | 0.377 (0.338-0.412) |
| White blood cell count, ×103/μL blood | 7.93 (5.85-7.75) | 5.33 (4.35-6.50) |
| . | ITP . | Healthy control . |
|---|---|---|
| Number of individuals | 9 | 9 |
| Age, y | 62 (51-71) | ∗ |
| Males/females (n/n) | 8/1 | ∗ |
| ITP category (chronic/new diagnosis) | 4/5 | |
| Platelet count, ×103/μL blood | 8.5 (1-45) P < .00001† | 194 (173-218) |
| Mean platelet volume (fL) | 8.91 (7.60- 9.75) P = .013† | 7.07 (7.0-8.0) |
| RBC count, ×109/μL blood | 4.14 (3.94-4.45) | 4.22 (3.64-4.58) |
| Hemoglobin, g/dL | 132 (127-138) | 134 (121-146) |
| Hematocrit, % | 0.376 (0.351-0.399) | 0.377 (0.338-0.412) |
| White blood cell count, ×103/μL blood | 7.93 (5.85-7.75) | 5.33 (4.35-6.50) |